BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32961634)

  • 1. Metabolomic analysis of fibrotic mice combined with public RNA-Seq human lung data reveal potential diagnostic biomarker candidates for lung fibrosis.
    Nojima Y; Takeda Y; Maeda Y; Bamba T; Fukusaki E; Itoh MN; Mizuguchi K; Kumanogoh A
    FEBS Open Bio; 2020 Nov; 10(11):2427-2436. PubMed ID: 32961634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of H4K16Ac levels reduces pro-fibrotic gene expression and mitigates lung fibrosis in aged mice.
    Zhang X; Liu H; Zhou JQ; Krick S; Barnes JW; Thannickal VJ; Sanders YY
    Theranostics; 2022; 12(2):530-541. PubMed ID: 34976199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. S100A12 as Biomarker of Disease Severity and Prognosis in Patients With Idiopathic Pulmonary Fibrosis.
    Li Y; He Y; Chen S; Wang Q; Yang Y; Shen D; Ma J; Wen Z; Ning S; Chen H
    Front Immunol; 2022; 13():810338. PubMed ID: 35185901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of lung apolipoprotein A-I in idiopathic pulmonary fibrosis: antiinflammatory and antifibrotic effect on experimental lung injury and fibrosis.
    Kim TH; Lee YH; Kim KH; Lee SH; Cha JY; Shin EK; Jung S; Jang AS; Park SW; Uh ST; Kim YH; Park JS; Sin HG; Youm W; Koh ES; Cho SY; Paik YK; Rhim TY; Park CS
    Am J Respir Crit Care Med; 2010 Sep; 182(5):633-42. PubMed ID: 20463180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of FAPα assessment in bronchoalveolar lavage as a marker of fibrogenesis: results of a preclinical study and first report in patients with idiopathic pulmonary fibrosis.
    Lavis P; Pingitore J; Doumont G; Garabet A; Van Simaeys G; Lacroix S; Passon N; Van Heymbeek C; De Maeseneire C; Allard J; Collin A; Huaux F; Decaestecker C; Salmon I; Goldman S; Cardozo AK; Bondue B
    Respir Res; 2023 Oct; 24(1):254. PubMed ID: 37880678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced endogenous secretory RAGE in blood and bronchoalveolar lavage fluid is associated with poor prognosis in idiopathic pulmonary fibrosis.
    Yamaguchi K; Iwamoto H; Mazur W; Miura S; Sakamoto S; Horimasu Y; Masuda T; Miyamoto S; Nakashima T; Ohshimo S; Fujitaka K; Hamada H; Hattori N
    Respir Res; 2020 Jun; 21(1):145. PubMed ID: 32527263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the metabolomic and lipidomic changes in the bleomycin model of pulmonary fibrosis in young and aged mice.
    Weckerle J; Picart-Armada S; Klee S; Bretschneider T; Luippold AH; Rist W; Haslinger C; Schlüter H; Thomas MJ; Krawczyk B; Fernandez-Albert F; Kästle M; Veyel D
    Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 34845494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRP14 is elevated in the bronchoalveolar lavage fluid of fibrosing interstitial lung diseases.
    Korthagen NM; Nagtegaal MM; van Moorsel CH; Kazemier KM; van den Bosch JM; Grutters JC
    Clin Exp Immunol; 2010 Aug; 161(2):342-7. PubMed ID: 20550547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Pro-Fibrotic Macrophage Populations by Single-Cell Transcriptomic Analysis in West Highland White Terriers Affected With Canine Idiopathic Pulmonary Fibrosis.
    Fastrès A; Pirottin D; Fievez L; Tutunaru AC; Bolen G; Merveille AC; Marichal T; Desmet CJ; Bureau F; Clercx C
    Front Immunol; 2020; 11():611749. PubMed ID: 33384697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mononuclear phagocytes and airway epithelial cells: novel sources of matrix metalloproteinase-8 (MMP-8) in patients with idiopathic pulmonary fibrosis.
    Craig VJ; Polverino F; Laucho-Contreras ME; Shi Y; Liu Y; Osorio JC; Tesfaigzi Y; Pinto-Plata V; Gochuico BR; Rosas IO; Owen CA
    PLoS One; 2014; 9(5):e97485. PubMed ID: 24828408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of high mobility group box1 in pulmonary fibrosis.
    Hamada N; Maeyama T; Kawaguchi T; Yoshimi M; Fukumoto J; Yamada M; Yamada S; Kuwano K; Nakanishi Y
    Am J Respir Cell Mol Biol; 2008 Oct; 39(4):440-7. PubMed ID: 18441281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of herpes simplex virus type-1 in patients with fibrotic lung diseases.
    Lasithiotaki I; Antoniou KM; Vlahava VM; Karagiannis K; Spandidos DA; Siafakas NM; Sourvinos G
    PLoS One; 2011; 6(12):e27800. PubMed ID: 22205929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.
    Korthagen NM; van Moorsel CH; Barlo NP; Ruven HJ; Kruit A; Heron M; van den Bosch JM; Grutters JC
    Respir Med; 2011 Jan; 105(1):106-13. PubMed ID: 20888745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Essential role of stem cell factor-c-Kit signalling pathway in bleomycin-induced pulmonary fibrosis.
    Ding L; Dolgachev V; Wu Z; Liu T; Nakashima T; Wu Z; Ullenbruch M; Lukacs NW; Chen Z; Phan SH
    J Pathol; 2013 Jun; 230(2):205-14. PubMed ID: 23401096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases.
    Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL
    APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNA-155/liver X receptor pathway in experimental and idiopathic pulmonary fibrosis.
    Kurowska-Stolarska M; Hasoo MK; Welsh DJ; Stewart L; McIntyre D; Morton BE; Johnstone S; Miller AM; Asquith DL; Millar NL; Millar AB; Feghali-Bostwick CA; Hirani N; Crick PJ; Wang Y; Griffiths WJ; McInnes IB; McSharry C
    J Allergy Clin Immunol; 2017 Jun; 139(6):1946-1956. PubMed ID: 27746237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MMP1 and MMP7 as potential peripheral blood biomarkers in idiopathic pulmonary fibrosis.
    Rosas IO; Richards TJ; Konishi K; Zhang Y; Gibson K; Lokshin AE; Lindell KO; Cisneros J; Macdonald SD; Pardo A; Sciurba F; Dauber J; Selman M; Gochuico BR; Kaminski N
    PLoS Med; 2008 Apr; 5(4):e93. PubMed ID: 18447576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.